Bio-Rad Laboratories | BIO - Action





Action Changement Date
Abbott USD 6.49B 220M 2025-12
Agilent USD 1.06B 34M 2025-12
Becton, Dickinson and Co. USD 4.08B 191M 2025-12
Bio Techne USD 205.45M 2.26M 2025-12
Bio-Rad Laboratories USD 740.7M 42.5M 2025-12
Bruker USD 1.2B 21.7M 2025-09
Charles River Laboratories USD 299.1M 3.45M 2025-12
Danaher USD 2.61B 119M 2026-03
General Electric Aerospace USD 12.37B 499M 2026-03
Illumina USD 564M 26M 2025-12
Laboratory Of America USD 534.7M 13.2M 2025-12
Merck USD 6.44B 157M 2025-09
Mettler Toledo International USD 387.23M 14.58M 2025-12
Myriad Genetics USD 30.6M 1000K 2025-12
OraSure Technologies USD 31.06M 2.34M 2025-12
Pacific Biosciences Of California USD 49.28M 3.87M 2025-12
Quest Diagnostics USD 225M 36M 2026-03
Repligen USD 170.46M 10.14M 2025-12
Revvity USD 379.5M 420K 2025-12
Roche Holding CHF 7.6B 9M 2025-06
Siemens EUR 10.26B 906M 2025-09
Standard Biotools USD 19.98M 5.44M 2025-12
Thermo Fisher Scientific USD 5.5B 71M 2026-03
Tosoh JPY 248.86B 3.81B 2025-09
Waters USD 572.37M 570K 2025-12